Toolkit may help families discuss cancer gene risks
NCT ID NCT04428736
First seen Apr 23, 2026 · Last updated Jun 08, 2026 · Updated 9 times
Summary
This study looked at whether giving a 'disclosure toolkit' to people with BRCA gene mutations helps them share their genetic test results with family members who may also be at risk. Researchers enrolled 52 adults with BRCA1 or BRCA2 mutations and tracked how often they told relatives and whether those relatives then got tested themselves. The goal was to find better ways to communicate cancer risk within families.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.